Category Archives: Hormone Replacement Therapy

Unfortunately, Premature Ovarian Insufficiency (POI) is a condition which isnt widely talked about, despite its prevalence. It is estimated that POI occurs in around 1 in 100 women under the age of 40, 1 in 1000 women under the age of 30 and 1 in 10,000 women under the age of 20. There are far-reaching physical and emotional consequences for sufferers of POI. The condition can result in a lower quality of life, impacting sexuality, mental and cognitive health, fertility, bone health and cardiovascular health.

More than ever, women are a valuable and vital asset to the workforce, but the reality is our behaviour is driven by our hormones and we have to navigate that rollercoaster from puberty, motherhood and then menopause. The journey is often unpredictable but especially when the menopausal period is brought forward bringing different issues that need support into the spotlight. Education for employers, women and men is key about the impact of womens hormones and how workplace culture needs to adapt to celebrate diversity, inclusivity and bridge the gender gap.

POI results in decreased sex hormone production as ovulation is brought to a halt. Sex hormones (estrogen, progesterone and testosterone) are crucial to our health and this cannot be emphasised enough. Often the cause of POI is unknown or genetic but it can be a cruel side effect of gynaecological surgery, particularly endometrial or ovarian cancer. Other cancer treatments such as chemotherapy or pelvic radiation are also implicated. There is a link of POI with diabetes, thyroid conditions, and autoimmune disorders so superimposing this on pre-existing health challenges is a double blow. Both underdiagnosis and misdiagnosis of POI is common and 25% of women say their diagnosis took more than 5 years and 50% or more will see three or more specialists before diagnosis is it a wonder it creates so much angst?

It is important to note that 25 % of women with POI do not experience these symptoms initially as their younger physiology can compensate but may at a later stage. Due to health issues and other conditions associated with POI, the average life expectancy of a woman with POI is 2 years less. The immediate threats to this younger group of women are mental health, fertility, and sexual functioning which impacts their relationships and well-being. Immediate support and focus is paramount to effective care.

Addressing the stigma of menopause in society and women themselves feeling it is a taboo subject is a fundamental but symbiotic shift. Women need to empower and be empowered. How can this translate into the workplace so we can optimise the necessary support and create a culture of menopause dignity? There needs to be a greater sensitivity with POI as these women bear a greater psychological burden with other underlying health conditions and the big fertility issue. They may also be at a time where they are developing their careers, feel they need to prove themselves, and have economic and family pressures which the older menopausal women is beyond. In summary, the needs of women with POI are complex and different and employers may not link menopause with their younger employees, who are suffering in silence. It is recognised that open communication and changes to the working environment can go far in reducing the impact of someones symptoms.

Employers have a corporate social responsibility to formulate HR policies and practices to support menopause and POI in the workplace. Every manager and employer should have access to high-quality information and education about menopause and POI issues to enable appropriate support of their teams. This ensures menopause gets the same understanding as any other health issue which will boost morale, retain valuable skills and talent and reduce sickness absence. Good communication skills such as sensitivity, empathy, active listening and non-judgement will encourage women to talk with honesty. Open communication must be facilitated with conversations about relevant issues to break down barriers so gauging and promoting awareness.

Performance must be managed proactively and positively with attention paid to the root cause if there appears to be a problem. The approach should be positive and supportive, taking into account underlying health conditions. Extra support and coaching can then be identified and reasonable time scales for improvement can be set. Regular informal dialogue will build trust and improve resilience.

Employers have a legal duty to ensure proper working conditions and remove discriminatory barriers to progression for women. Organisations such as CIPD and ACAS provide guidelines and resources on how to develop menopause policy in the workplace.

Psychological issues are prevalent in POI, and women must be empowered to discuss concerns with their line manager so adjustments can be made to work duties causing a particular challenge. Some companies have employed a menopause or wellbeing champion for this purpose so women can be directed to relevant counselling services and seek medical advice. Women with POI must be seen in a specialist clinic and ideally offered bioidentical hormone replacement therapy tailored to their needs, holistic support for immediate problems such as sexual dysfunction and monitoring of long term health conditions such as DEXA bone scans to assess osteoporosis risk. POI women might need time off for fertility treatments such as IVF and egg donation which can be extremely stressful and there is no guarantee of success for the amount of emotional and financial investment pumped in. The Daisy Network is a charity dedicated to providing information and support for POI.

Employers must identify reasonable adjustments that can create an inclusive space for women and there must be capacity for risk assessment for each individual employee. Easy access to washrooms and sanitary products should be considered. Changes such as moving a desk to the window, ensuring ergonomics of the workspace, providing fans, cool drinking water and regular rest breaks are a welcome relief for problematic symptoms and engender goodwill. Flexible working patterns are important such as part-time working and surely the ability to work from home rather than taking a day off is a better solution to workplace productivity. There has been a huge culture shift in working from home due to the current pandemic. Zoom has boomed! We have been positively coerced into making productive work arrangements and the benefits and possibilities in our digital age are vast.

Women comprise 50% of the UK workforce represented in all sectors and at all levels including top executive and governmental positions indeed the country voted as having the best response to the coronavirus pandemic has Jacinda Ardern, the youngest female prime minister at its helm! What a role model for the world. A 21st-centuryenvironment should be inclusive to both sexes and enable us to rightfully thrive in the workplace and community.

Editor's Recommended Articles

Originally posted here:
Suffering with Premature Ovarian Insufficiency (POI) in the workplace - Open Access Government

Fort Collins, Colorado: Reports Globe added the latest research report on future growth opportunities, development trends, and forecasts for 2027 of the Hormone Replacement Therapy Market. Global Hormone Replacement Therapy Market Report provides an overview of the segments and sub-segments including Product Types, Applications, Companies, and Regions. This report describes the overall size of the Hormone Replacement Therapy market through analysis of historical data and future forecasts.

The report presents unique and pertinent factors that are expected to have a material impact on the Hormone Replacement Therapy market during the forecast period. This report also provides an analysis of the impact of the COVID-19 pandemic on the Hormone Replacement Therapy market. This report contains a substantial and detailed amount of information that will provide new entrants with the most complete understanding. The report explains the historical and current trends that are shaping the growth of the Hormone Replacement Therapy market.

(Exclusive Offer: Flat 30% discount on this report)

Request a Sample Before Buying this Report @ https://reportsglobe.com/download-sample/?rid=105100

The Following Companies are Major Contributors to the Hormone Replacement Therapy Market Research Report:

Segment Analysis

The report categorizes the Hormone Replacement Therapy industry by segment, including product type and application. Each segment is valued based on its growth rate and share. In addition, analysts examined potential regions that could prove useful for Hormone Replacement Therapy manufacturers in the coming years. The regional analysis includes reliable value and volume forecasts and thus helps market participants to better understand the Hormone Replacement Therapy industry as a whole.

Hormone Replacement Therapy Market Segmentation, By Type

Hormone Replacement Therapy Market Segmentation, By Application

Request a Discount on the report @ https://reportsglobe.com/ask-for-discount/?rid=105100

Geographical scenario:

-Middle East and Africa (Gulf States and Egypt)-North America (USA, Mexico and Canada)-South America (Brazil etc.)-Europe (Turkey, Germany, Russia, UK, Italy, France, etc.)-Asia Pacific (Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia)

Scope of the Report:

The Hormone Replacement Therapy Market Research Report is a comprehensive publication that aims to determine the financial outlook for the market. For the same reason, it offers a detailed understanding of the competitive landscape. It examines some of the leading players, their leadership styles, their status in research and development, and their expansion strategies.

The report also includes product portfolios and a list of products in development. It provides a detailed explanation of the advanced technologies and investments to upgrade existing technologies.

Collectively, this research repository encapsulates data of Hormone Replacement Therapy market to offer strategic decision-making abilities to various investors, business owners, decision-makers as well as policymakers.

View market snapshot before purchasing @ https://reportsglobe.com/product/global-hormone-replacement-therapy-market-insight-and-forecast/

Key questions answered in the report:

1. What is the Keyword Markets Growth Potential?2. Which product segment will get the lions share?3. Which regional market will lead in the coming years?4. Which application segment will grow steadily?5. What growth opportunities could arise in the Hormone Replacement Therapy industry in the coming years?6. What are the main challenges for the Hormone Replacement Therapy market in the future?7. Which companies lead the Hormone Replacement Therapy market?8. What are the main trends that are positively influencing market growth?9. What growth strategies are players considering to stay in the Hormone Replacement Therapy market?

Table of Contents

1 scope of research2 summary3 Competition from manufacturers4 Market size by type5 Market size by application6 Market Size by Region7 Company profileEight value chain and sales channel analyzes9 Analysis of market drivers, opportunities, challenges and risk factors10 key findings from the Hormone Replacement Therapy study11 Appendix

Request customization of the report @ https://reportsglobe.com/need-customization/?rid=105100

Key target audience for Hormone Replacement Therapy report:

The report is insightful documentation and provides significant insights to customers, business owners, decision-makers, providers, distributors, suppliers, policymakers, manufacturers, investors, and individuals who have a keen interest in the Hormone Replacement Therapy market.

How Reports Globe is different than other Market Research Providers:

The inception of Reports Globe has been backed by providing clients with a holistic view of market conditions and future possibilities/opportunities to reap maximum profits out of their businesses and assist in decision making. Our team of in-house analysts and consultants works tirelessly to understand your needs and suggest the best possible solutions to fulfill your research requirements.

Our team at Reports Globe follows a rigorous process of data validation, which allows us to publish reports from publishers with minimum or no deviations. Reports Globe collects, segregates, and publishes more than 500 reports annually that cater to products and services across numerous domains.

Contact us:

Mr. Mark Willams

Account Manager

US: +1-970-672-0390

Email: [emailprotected]

Website: Reportsglobe.com

Sarkari Results, Thrive Market Research

Originally posted here:
Hormone Replacement Therapy Market Size, Growth And Key Players- Eli Lilly, Teva, Novo Nordisk, Pfizer, Bayer The Bisouv Network - The Bisouv Network

Fort Collins, Colorado: Reports Globe added the latest research report on future growth opportunities, development trends, and forecasts for 2027 of the Bio-identical Hormone Replacement Therapy Market. Global Bio-identical Hormone Replacement Therapy Market Report provides an overview of the segments and sub-segments including Product Types, Applications, Companies, and Regions. This report describes the overall size of the Bio-identical Hormone Replacement Therapy market through analysis of historical data and future forecasts.

The report presents unique and pertinent factors that are expected to have a material impact on the Bio-identical Hormone Replacement Therapy market during the forecast period. This report also provides an analysis of the impact of the COVID-19 pandemic on the Bio-identical Hormone Replacement Therapy market. This report contains a substantial and detailed amount of information that will provide new entrants with the most complete understanding. The report explains the historical and current trends that are shaping the growth of the Bio-identical Hormone Replacement Therapy market.

(Exclusive Offer: Flat 30% discount on this report)

Request a Sample Before Buying this Report @ https://reportsglobe.com/download-sample/?rid=102995

The Following Companies are Major Contributors to the Bio-identical Hormone Replacement Therapy Market Research Report:

Segment Analysis

The report categorizes the Bio-identical Hormone Replacement Therapy industry by segment, including product type and application. Each segment is valued based on its growth rate and share. In addition, analysts examined potential regions that could prove useful for Bio-identical Hormone Replacement Therapy manufacturers in the coming years. The regional analysis includes reliable value and volume forecasts and thus helps market participants to better understand the Bio-identical Hormone Replacement Therapy industry as a whole.

Bio-identical Hormone Replacement Therapy Market Segmentation, By Type

Bio-identical Hormone Replacement Therapy Market Segmentation, By Application

Request a Discount on the report @ https://reportsglobe.com/ask-for-discount/?rid=102995

Geographical scenario:

-Middle East and Africa (Gulf States and Egypt)-North America (USA, Mexico and Canada)-South America (Brazil etc.)-Europe (Turkey, Germany, Russia, UK, Italy, France, etc.)-Asia Pacific (Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia)

Scope of the Report:

The Bio-identical Hormone Replacement Therapy Market Research Report is a comprehensive publication that aims to determine the financial outlook for the market. For the same reason, it offers a detailed understanding of the competitive landscape. It examines some of the leading players, their leadership styles, their status in research and development, and their expansion strategies.

The report also includes product portfolios and a list of products in development. It provides a detailed explanation of the advanced technologies and investments to upgrade existing technologies.

Collectively, this research repository encapsulates data of Bio-identical Hormone Replacement Therapy market to offer strategic decision-making abilities to various investors, business owners, decision-makers as well as policymakers.

View market snapshot before purchasing @ https://reportsglobe.com/product/global-bio-identical-hormone-replacement-therapy-market-insight-and-forecast/

Key questions answered in the report:

1. What is the Keyword Markets Growth Potential?2. Which product segment will get the lions share?3. Which regional market will lead in the coming years?4. Which application segment will grow steadily?5. What growth opportunities could arise in the Bio-identical Hormone Replacement Therapy industry in the coming years?6. What are the main challenges for the Bio-identical Hormone Replacement Therapy market in the future?7. Which companies lead the Bio-identical Hormone Replacement Therapy market?8. What are the main trends that are positively influencing market growth?9. What growth strategies are players considering to stay in the Bio-identical Hormone Replacement Therapy market?

Table of Contents

1 scope of research2 summary3 Competition from manufacturers4 Market size by type5 Market size by application6 Market Size by Region7 Company profileEight value chain and sales channel analyzes9 Analysis of market drivers, opportunities, challenges and risk factors10 key findings from the Bio-identical Hormone Replacement Therapy study11 Appendix

Request customization of the report @ https://reportsglobe.com/need-customization/?rid=102995

Key target audience for Bio-identical Hormone Replacement Therapy report:

The report is insightful documentation and provides significant insights to customers, business owners, decision-makers, providers, distributors, suppliers, policymakers, manufacturers, investors, and individuals who have a keen interest in the Bio-identical Hormone Replacement Therapy market.

How Reports Globe is different than other Market Research Providers:

The inception of Reports Globe has been backed by providing clients with a holistic view of market conditions and future possibilities/opportunities to reap maximum profits out of their businesses and assist in decision making. Our team of in-house analysts and consultants works tirelessly to understand your needs and suggest the best possible solutions to fulfill your research requirements.

Our team at Reports Globe follows a rigorous process of data validation, which allows us to publish reports from publishers with minimum or no deviations. Reports Globe collects, segregates, and publishes more than 500 reports annually that cater to products and services across numerous domains.

Contact us:

Mr. Mark Willams

Account Manager

US: +1-970-672-0390

Email: [emailprotected]

Website: Reportsglobe.com

Sarkari Results, Thrive Market Research

Read the original post:
Bio-identical Hormone Replacement Therapy Market Size, Growth And Key Players- RevitaLife, US Compounding, Aesthetics&Wellness, The Bisouv Network -...

A CORK woman is marking three years of being cancer-free with a new baby and a fundraiser for the charity that was her safe place while she was sick.

Nuala OBrien was just 23 when she by chance discovered that she had cancer after a fall on a night out.

The Glanworth native cut her hand went to A&E where a student staff member she got chatting to asked if she could practice conducting a chest X-ray.

The X-ray would reveal that 23-year-old Nuala had Hodgkins lymphoma.

Diagnosed with stage 2 cancer, Nuala was told that if it had not been detected when it was, she may not have lived to see her birthday which was just six months away.

They said that because I had no symptoms and how fast it was growing, I probably wouldnt have seen my birthday in the April, so I was lucky I fell when I did, she said.

When she was first diagnosed, her family had been persuading her to attend the Cork Cancer Care Centre, but she had been reluctant.

However, after a relapse, she decided to try it out and it quickly became her safe place.

I was only 23 when I first got diagnosed and I didnt know anybody else that had cancer, she said.

When I was out in public and I was out with other people, I was the only sick person and it was really obvious that I was sick and people would give you a look and people are always asking how you are getting on whereas when you get into the centre, everyone is like that and no one talks about being sick.

The Cork Cancer Care Centre was founded in 2011 and acts as a home away from home for those who have touched by cancer, with a number of supports for families and individuals.

It was kind of like a safe place that you could go and be normal and not have everyone feel sorry for you, she added.

During her treatment, Nuala had experienced menopause at just 24-years of age.

I was told I would never have kids and I was put straight on hormone replacement therapy patches just to help with the side effects of menopause.and then I just kind of accepted that I could never have kids.

However, shortly after celebrating her second year of being cancer-free, she discovered that she was pregnant with baby Shay.

Each Valentines Day, Nuala marks her anniversary of being cancer-free by raising money for the centre and this year, she celebrated the three-year mark alongside her seven-month-old son, Shay.

Over the past number of years, she has experienced a lot of unexpected changes in life, but her support for the Cork Cancer Care Centre will continue throughout the years of celebrating the important milestone.

Its a charity that I know forever will be really, really close to our hearts and that we will always be doing as much as we can for them because they have done so much for us. Donations can be made on @togetherwearestandinguptocancer on Facebook or on corkcancercarecentre.ie.

See the rest here:
Cork woman told she would never have children celebrates baby joy and clean bill of health 3 years after shock cancer diagnosis - EchoLive.ie

VALLEY COTTAGE, N.Y. Impact of COVID-19 on the Healthcare Industry

The COVID-19 pandemic has causedsevere impacts on the global economy at various levels and which can be seen onthe Healthcare industry as well. The thriving market of health care research anddevelopment is expected to exhibit a steep decline in the sales during thelockdown period owing to the shutdown of the manufacturing units, acuteshortage in the supply of raw materials and absence of potential manpower. Itcan be deduced from the current situations brought about by the pandemic thatthe production, and supply chain activities have experienced minor hurdles.However, the market is projected to gradually recover post-COVID-19, which willpresent attractive opportunities for sales across various regions of the worldin the following years.

Future Market Insights (FMI) adopteda multidisciplinary approach during the pandemic-era to focus on the growth anddevelopment of the HormoneReplacement Therapy Market. The study features insights on the currentgrowth dynamics and the major revenue reforms prevailing in the market as alongwith the key takeaways over the forecast.

The team of analysts at Future MarketInsights are focussing on research and market study to produce different HormoneReplacement Therapy Market forecasts and predictions at both national andinternational levels. They have considered several leads of informationpertaining to the industry like market figures and merger estimations to assessand produce reliable and informative insights on the Hormone ReplacementTherapy Market.

To remain ahead of your competitors, Ask aQuestion >> https://www.futuremarketinsights.com/ask-question/rep-gb-3871

Key Players

The writer will create content on thegeneral strategies of market players. And then will write the key players inthe market are: Bayer AG, Pfizer, Merck & co., BioSante Pharmaceuticals andAmgen, QuatRx Pharmaceuticals, Noven Pharmaceuticals

Segmentation

The report provides insights on the important highlights and currenttrends prevailing in the market. This helps the readers to gain a deeperunderstanding and form an unbiased opinion on the market. Numeroussegmentations have been provided for this market based on:

Based on TherapyType,

Based onApplication

Based onDistribution Channel

ProductSegmentation

Theinvestigation offers a top to bottom evaluation of different clients journeyspertinent to the market and its segments.The studyendeavours to assess the current and future development possibilities, undiscoveredroads, factors that shapes their income potential in the global market bybreaking it into di such as its types, applications, and region-wiseassessment.

Get Access to Research Methodology Prepared byExperts >>https://www.futuremarketinsights.com/askus/rep-gb-3871

By RegionalAnalysis Covered

Fullin-depth analysis of the parent market

The analysts at FMI are dedicated toprovide insights after extensive research and study. The study also includesestimations, projections and evaluation of the market dynamics.

Importantchanges in market dynamics

The report has beencreated after detailed and exhaustive studies by the analysts at FMI takingseveral factors into consideration like monetary, ecological, social,mechanical, and political status of a particular demography. They study the keydata to assess the revenue and production of manufacturers across variousregions. The report also covers an in-depth analysis ofthe key changes in market dynamics in the recent past and the near future.

Segmentationdetails of the market

Queries Solved

To receive extensive list of importantregions, ask for TOC here >>https://www.futuremarketinsights.com/toc/rep-gb-3871

Table of Content

Reasons to Buythe report

Explore Wide-ranging Coverage of FMIs HealthcareLandscape

Respiratory Inhaler Devices MarketA slew of new drugs were launched for the management of asthma and COPD overthe last decade and development of more are currently underway. With leadingdrug manufacturers expecting the demand to surge amid COVID-19, respiratoryinhaler sales are set to grow steadily through 2030.

Microbial Therapeutic Products MarketThe global microbial therapeutic products market is poised to expand robustlyat a value CAGR worth 7% across the 2020-2030 assessment period. Risingprevalence of lifestyle induced chronic disorders as well as antimicrobialresistance are primarily driving the markets growth.

Transradial Closure Devices MarketAccording to Future Market Insights (FMI), the demand from hospitals,independent catheterization centers, and healthcare clinics will continuerising. Spurred by this, the global transradial closure devices market is setto grow by 6.5% CAGR during the forecast period from the year 2020 to 2030.

About FMI

Future Market Insights (FMI) is a leading provider of marketintelligence and consulting services, serving clients in over 150countries.FMIisheadquartered in Dubai, the global financial capital, and has delivery centersin the U.S. and India. FMIs latestmarketresearch reportsand industry analysis help businesses navigatechallenges and make critical decisions with confidence and clarity amidstbreakneck competition. Our customized and syndicated market research reportsdeliver actionable insights that drive sustainable growth. A team of expert-ledanalysts at FMI continuously tracks emerging trends and events in a broad rangeof industries to ensure that our clients prepare for the evolving needs oftheir consumers.

ContactUs

Mr. Abhishek BudholiyaUnit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,Jumeirah Lakes Towers,Dubai,United Arab EmiratesMARKET ACCESS DMCC InitiativeFor Sales Enquiries:sales@futuremarketinsights.comFor Media Enquiries:press@futuremarketinsights.comWebsite:https://www.futuremarketinsights.com

Continued here:
Hormone Replacement Therapy Market By 2027 Top Winning Strategies, COVID-19 Impacting Factors, Busin - PharmiWeb.com

The report byZion Market Researchtitled Hormone Replacement Therapy Market: Global Industry Analysis, Size, Share, Growth, Trends, And Forecast, 2020-2026 presents aprofound comprehension regarding the functioning and expansion of theHormone Replacement Therapy Marketon regional and global level. This analysis report is the collation of all the wide-ranginginformation relating to the market statistics during the recent years as well as forecasts for coming years. To begin with, the report comprises the major players actively participating and competing within the Hormone Replacement Therapy market; it entails several companies, manufacturers, suppliers, organizations, and so on. Thus, the report will assist in understanding the initiatives and approaches implemented by these players to create and reinforce their market presence. The thoroughanalysis presents a wide-ranging comprehension of the global market in a knowledgeableway. The client can merely point out the steps of the firm by having details regarding their global revenue, market share, price, production & capacity, andrecent developments during the forecast period.

FREE | Request Sample is Available @https://www.zionmarketresearch.com/sample/hormone-replacement-therapy-market

Global Hormone Replacement Therapy Market: Competitive Players

Pfizer, BioSante Pharmaceuticals and Amgen, Noven Pharmaceuticals, Bayer AG, Merck & co., and QuatRx Pharmaceuticals.

The research report includes the outline of the global Hormone Replacement Therapy market such as definition, classifications, and applications. Apart from this, it entails the comprehensiveassessment of a number of factors like constraints, opportunities, drivers, challenges,and risk. Further, it the global Hormone Replacement Therapy market is bifurcated on the basis of diverse parameters into respective segments as well as sub-segments. The report alsoencompasses the existing, previous, and likely growth trends within the market for each segment and sub-segment. Additionally, the market is also segregated based on regions North America, Europe, Asia-Pacific and Latin America. along with detailed evaluation of their growth, key developments & strategies, opportunities, and the key patterns influencing the market expansion in those regions.The report will further also entail a particular part putting forth the changes and of the ongoing COVID-19pandemic. It comprisesin-depth market analysis rooted on the predictions of post-COVID-19 market circumstances together with data on the existing impacts on the Hormone Replacement Therapy market of the pandemic.

Promising Regions & Countries Mentioned In The Hormone Replacement Therapy Market Report:

Download Free PDF Report Brochure @https://www.zionmarketresearch.com/requestbrochure/hormone-replacement-therapy-market

The research report also highlights the wide array of tacticalsteps, such as latest business deals, joint ventures, partnerships, M&As, technological developments, and launch of new products taking placing in the market. In addition, it scrutinizesseveral patterns of the global Hormone Replacement Therapy market, entailing the rules, criteria, and policy deviationsimplemented by the private companies and government on the market over the last few years. As a final point, the analysis includes forecasts and historic data making it a beneficial asset for experts, industry executives, presentation, sales & product managers, consultants, and every other person or organization looking for essential market data and statistics.

Key Details & USPs of the Existing Report Study:

Request coronavirus impact analysis on sectors and market

Inquire more about this report @https://www.zionmarketresearch.com/inquiry/hormone-replacement-therapy-market

What Reports Provides

Also, Research Report Examines:

Thanks for reading this article;you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.

Follow this link:
Global Hormone Replacement Therapy Market Research Report Covers, Future Trends, Past, Present Data and Deep Analysis 2020-2026 KSU | The Sentinel...

SAN DIEGO, Feb. 16, 2021 (GLOBE NEWSWIRE) -- DarBioscience, Inc. (NASDAQ: DARE), a leader in womens health innovation, today announced thatSabrina Martucci Johnson, its President and Chief Executive Officer, will participate in a live panel discussion titled, The Evolution of Birth Control: Considerations from Product Development to End-User Adoption from Leading Innovators, at 12:30 p.m. EST / 9:30 a.m. PST on Tuesday, February 23, 2021, at the Womens Health Innovation Series: Contraception Innovation Summit, which will be held virtually.

The panel will discuss the opportunities and challenges faced by innovators when advancing new methods of birth control. As a featured speaker, Ms. Johnson will share Dars commitment to addressing unmet needs in contraception and the Companys own journey with three innovative product candidates under development: Ovaprene, an investigational hormone-free, monthly contraceptive that the Company is advancing towards a pivotal contraceptive study and whoseU.S.commercial rights are under a license agreement with Bayer; DARE-LARC1, an investigational user-controlled long acting reversible levonorgestrel drug delivery system designed to store in a single implant and precisely deliver hundreds of therapeutic doses over months or years, whose development has been supported by $20.5 million in grant funding from the Bill & Melinda Gates Foundation; and ORB-204 and ORB-214, investigational injectable formulations of etonogestrel being developed as longer-acting (6- and 12-months) methods of contraception with a more predictable return to fertility compared to currently marketed injectable contraceptive products.

The Contraception Innovation Summit is part of the 2021 Womens Health Innovation Series. The Summit is about putting women at the center of contraceptive research, innovations,and education to improve womens contraceptive journeys throughout their lives. Participants will include a leading network of pharma, biotech, medical device companies, start-ups, investors, researchers, and health care providers driving innovation at the convergence of healthcare and technology.

Find out more by downloading the agenda

About Dar Bioscience

Dar Bioscience is a clinical-stage biopharmaceutical company committed to the advancement of innovative products for womens health. The companys mission is to identify, develop and bring to market a diverse portfolio of differentiated therapies that expand treatment options, improve outcomes and facilitate convenience for women, primarily in the areas of contraception, vaginal health, sexual health, and fertility.

Dars product portfolio includes potential first-in-category candidates in clinical development: Ovaprene, a hormone-free, monthly contraceptive intravaginal ring whoseU.S.commercial rights are under a license agreement with Bayer; Sildenafil Cream, 3.6%, a novel cream formulation of sildenafil to treat female sexual arousal disorder utilizing the active ingredient in Viagra; DARE-BV1, a unique hydrogel formulation of clindamycin phosphate 2% to treat bacterial vaginosis via a single application; and DARE-HRT1, a combination bio-identical estradiol and progesterone intravaginal ring for hormone replacement therapy following menopause. To learn more about Dars full portfolio of womens health product candidates, and mission to deliver differentiated therapies for women, please visitwww.darebioscience.com.

Dar may announce material information about its finances, product candidates, clinical trials and other matters using the Investors section of its website (http://ir.darebioscience.com),SECfilings, press releases, public conference calls and webcasts. Dar will use these channels to distribute material information about the company, and may also use social media to communicate important information about the company, its finances, product candidates, clinical trials and other matters. The information Dar posts on its investor relations website or through social media channels may be deemed to be material information. Dar encourages investors, the media, and others interested in the company to review the information Dar posts in the Investors section of its website and to follow these Twitter accounts: @SabrinaDareCEO and @DareBioscience. Any updates to the list of social media channels the company may use to communicate information will be posted on the investor relations page of Dars website mentioned above.

Contact:Investors on behalf of DarBioscience, Inc.:Tom MastersonAllele Capital Partnerstmasterson@allelecapital.com646.573.3216

Source: DarBioscience, Inc.

Read the original:
Dar Bioscience to Participate at the Women's Health Innovation Series: Contraception Innovation Summit to be held Virtually on February 23, 2021 -...

New Delhi:

This condition is referred to as andropause or in other words it is called as male menopause. It affects up to 30 per cent of men in their 50s and becomes more prevalent with age, says Dr Chandrika Kulkarni, Consultant Obstetrician Gynecologist and fertility specialist; Cloudnine Group of Hospitals.

''Unlike menopause in women, when hormone production stops completely, testosterone decline in men is a slower process. The testes, unlike the ovaries, do not run out of the substance it needs to make testosterone. However, subtle changes in the function of the testes may occur as early as age 45 to 50 and more dramatically after the age of 70 in some men," the doctor tells IANSlife.

Male menopause differs from female menopause in several ways. Not all men experience andropause and also it doesn't involve a complete shutdown of the reproductive organs. Sexual complications may arise as a result of lowered hormone levels. Male menopause can cause physical, sexual, and psychological problems. The symptoms typically worsen as one gets older, she warns.

Watch out for the Symptoms

The doctor points out: "The symptom most associated with hypogonadism (low level of hormones) is low libido. Other manifestations of hypogonadism include: erectile dysfunction, decreased muscle mass and strength, increased body fat, decreased bone mineral density and osteoporosis, and decreased vitality and depressed mood. Osteoporosis is twice more common in hypogonadal (low level of hormones) men as compared to eugonadal (normal level of hormones) men (6 vs 2.8 per cent)."

How is Andropause diagnosed and what is its treatment? Dr Kulkarni answers:

It is recommended to test older men for low testosterone levels only if they have signs or symptoms. If an initial test shows low testosterone, the test should be repeated to confirm the results.

The initial treatment for symptoms of male menopause is making healthier lifestyle choices.

Healthy diet

Regular exercise

Adequate sleep

Reducing stress levels

These lifestyle habits can benefit all men. After adopting these habits, men who are experiencing symptoms of male menopause may see a dramatic change in their overall health. It's normal to experience a decline in testosterone levels as one gets older. For many men, the symptoms are manageable even without treatment. If the symptoms are cause hardship, consultation with the specialist is advised. They can provide recommendations to help manage or treat symptoms.

Hormone replacement therapy is another treatment option. However, testosterone replacement therapy has its own potential risks and side effects. Replacing testosterone may worsen prostate cancer and increase the risk of heart disease.

Original post:
Have you heard of male menopause? Andropause explained - DTNEXT

Some people use the term male menopause to refer to hormonal changes that men experience as they get older. Men experience symptoms resulting from a decrease in the male hormone called as testosterone. This condition is referred to as andropause or in other words it is called as male menopause. It affects up to 30 per cent of men in their 50s and becomes more prevalent with age, says Dr Chandrika Kulkarni, Consultant Obstetrician Gynecologist and fertility specialist; Cloudnine Group of Hospitals.

Unlike menopause in women, when hormone production stops completely, testosterone decline in men is a slower process. The testes, unlike the ovaries, do not run out of the substance it needs to make testosterone. However, subtle changes in the function of the testes may occur as early as age 45 to 50 and more dramatically after the age of 70 in some men, the doctor said.

Male menopause differs from female menopause in several ways. Not all men experience andropause and also it doesn't involve a complete shut-down of the reproductive organs. Sexual complications may arise as a result of lowered hormone levels. Male menopause can cause physical, sexual, and psychological problems. The symptoms typically worsen as one gets older, she warns.

Watch out for the symptoms: The doctor points out: "The symptom most associated with hypogonadism (low level of hormones) is low libido. Other manifestations of hypogonadism include: erectile dysfunction, decreased muscle mass and strength, increased body fat, decreased bone mineral density and osteoporosis, and decreased vitality and depressed mood. Osteoporosis is twice more common in hypogonadal (low level of hormones) men as compared to eugonadal (normal level of hormones) men (6 vs 2.8 per cent)."

How is Andropause diagnosed and what is its treatment? Dr Kulkarni answers:

It is recommended to test older men for low testosterone levels only if they have signs or symptoms. If an initial test shows low testosterone, the test should be repeated to confirm the results.

The initial treatment for symptoms of male menopause is making healthier lifestyle choices. Healthy diet, regular exercise, adequate sleep, reducing stress levels. These lifestyle habits can benefit all men.

After adopting these habits, men who are experiencing symptoms of male menopause may see a dramatic change in their overall health. It's normal to experience a decline in testosterone levels as one gets older. For many men, the symptoms are manageable even without treatment. If the symptoms are cause hardship, consultation with the specialist is advised. They can provide recommendations to help manage or treat symptoms.

Hormone replacement therapy is another treatment option. However, testosterone replacement therapy has its own potential risks and side effects. Replacing testosterone may worsen prostate cancer and increase the risk of heart disease.

Read more here:
Like women, men too suffer from menopause, its called Andropause - Free Press Journal

Pune, Maharashtra, India, February 12 2021 (Wiredrelease) Brandessence Market Research and Consulting Pvt ltd :The global Menopause Treatment Market is valued at USD 2406.0 Million in 2017 and expected to reach USD 3049.97 Million by 2027 with a CAGR of 2.4% over the forecast period.

Scope of Global Menopause Treatment Market Report:

Menopause is a natural process which marks the end of menstrual cycles and it is also known as Climacteric. It can also be associated by decrease in estrogen and progesterone levels. The typical age for experiencing menopause is 45 55 years and varies individually. Some women will find it difficult while going through this stage; symptoms include weight gain, hot flashes, and vaginal dryness. These symptoms continue for around 4 years after last period and for 12 years for around 10% of women. Menopause requires treatment for relieving the signs and preventing the chronic conditions related to it or occurs due to aging. In order to curb these symptoms there is a growing demand in medication and technology which can be the key benefits in menopause treatment market.

Get Sample of This Report@ https://brandessenceresearch.com/requestSample/PostId/1455

Global Menopause Treatment Market report is segmented on the basis of non-hormonal treatment, hormonal treatment, distribution channel and region & country level. Based on the non-hormonal treatment, the menopause treatment market is segmented into progesterone, estrogen and combination. Based upon hormonal treatment type, Global Menopause Treatment Market is classified into anti-migraine, anti-depressants, and anti-anxiety. Based upon distribution channel Global Menopause Treatment Market fragmented into Retail Pharmacies, online pharmacies, and hospital pharmacies.

The regions covered in this Global Menopause Treatment Market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, the market of Menopause Treatment is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, Middle East Asia, Africa, etc.

Key Players for Global Menopause Treatment Market Report:

Some major key players for Global Menopause Treatment Market are Fervent Pharmaceuticals, Pfizer, Merck, Novartis, Novo Nordisk, Cipla, Emcure Pharmaceuticals, Allergen plc, Teva Pharmaceuticals and others.

News: New Telemedicine Service

July 15th, 2020; The Cusp, new startup offering telemedicine services to predict the menopause. These services include, at-home hormone tests reducing the hospitals and labs costs. The telemedicine will cost up to $159 comparatively less with $500 for lab test and hospital consultations. The Cusp is providing care to around 200 patients and expanding its launch with other startups like CurieMD, Elektra Health and Geneve. Till date, company has raised around $4 million from the investors.

Changing lifestyle and increasing awareness among middle aged women are key driving factors for the growth of Global Menopause Treatment Market.

The major factor driving the growth of global menopause treatment market is awareness among middle aged women and their changing lifestyles. On the other hand, there is tremendous growth in menopausal symptoms and it is estimated that around 80% of women experience common symptoms like mood change, joint pain, headaches, hot flashes and night sweats. Therefore, NICE has recommended Hormone Replacement Therapy (HRT) for hot flashes and night sweats. Moreover, rising investment in R&D activities along with new product launches in the market is expected to fuel the growth of menopause treatment market. In some developing countries, discussing about menstrual cycles considered as taboo as well as lack of developed healthcare infrastructure is expected to hamper the growth of menopause treatment market. In addition, herbal and natural treatment options turn out to be the major opportunity and support the market growth in a long run.

North America is dominating the Global Menopause Treatment Market

North America is expected to dominate the Global Menopause Treatment Market within the forecast period attributed to the presence of developed healthcare infrastructure and supportive government initiatives for womens health. Moreover, surge in female population with menopause symptoms are also likely to raise the demand for treatment. According to the study published in journal of The North America Menopause Society (NAMS) the symptoms of menopause is correlated with job environment which affects the working women aged between 45 to 65 years. These symptoms affect them physically, psychologically and sexually. Furthermore, growth in R&D investment and development of novel treatment options are also expected to enhance the market growth.

Europe is the second largest developed region in menopause treatment market followed by North America. Asia Pacific is expected to develop at significant rate owing to surge in working female population supported by rising awareness. IN addition, increase in strategic collaborations in the region is also expected to fuel the market growth. Moreover, growth in technology and development in healthcare infrastructure is also expected to contribute the overall market growth.

Key Benefits for Global Menopause Treatment Market Report:

Global Menopause Treatment Market report covers in-depth historical and forecast analysis.

Global Menopause Treatment Market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market Opportunities, Competitive Analysis, Regional and Country Level.

Global Menopause Treatment Market report helps to identify opportunities in marketplace.

Global Menopause Treatment Market report covers extensive analysis of emerging trends and competitive landscape.

Global Menopause Treatment Market Segmentation:

By Non-Hormonal Treatment:

Progesterone

Estrogen

Combination

By Hormonal Treatment:

Anti-Migraine

Anti-Depressants

Anti-Anxiety

By Distribution Channel:

Retail Pharmacies

Online Pharmacies

Hospital Pharmacies

Menopause Treatment Market By Regional & Country Level:

North America

U.S.

Canada

Europe

U.K.

France

Germany

Italy

Asia Pacific

China

Japan

India

Southeast Asia

Latin America

Brazil

Mexico

Middle East and Africa

GCC

Africa

Rest of Middle East and Africa

Table of Content

1. Chapter Report Methodology1.1. Research Process1.2. Primary Research1.3. Secondary Research1.4. Market Size Estimates1.5. Data Triangulation1.6. Forecast Model1.7. USPs of Report1.8. Report Description

2. Chapter Global Menopause Treatment Market Overview: Qualitative Analysis2.1. Market Introduction2.2. Executive Summary2.3. Global Menopause Treatment Market Classification2.4. Market Drivers2.5. Market Restraints2.6. Market Opportunity2.7. Menopause Treatment Market: Trends2.8. Porters Five Forces Analysis2.9. Market Attractiveness Analysis

3. Chapter Global Menopause Treatment Market Overview: Quantitative Analysis

4. Chapter Global Menopause Treatment Market Analysis: Segmentation By Type

5. Chapter Global Menopause Treatment Market Analysis: Segmentation By Application

Continued.

Complete Report Details @ https://brandessenceresearch.com/healthcare/menopause-treatment-market

About Us: Brandessence Market Research and Consulting Pvt. ltd.

Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.

Contact us at: +44 2038074155 or mail us at sales@brandessenceresearch.com

Website: https://brandessenceresearch.com/

Article: https://businessstatsnews.com

This content has been published by Brandessence Market Research and Consulting Pvt ltd company. The WiredRelease News Department was not involved in the creation of this content. For press release service enquiry, please reach us at contact@wiredrelease.com.

Read more:
Menopause Treatment Market Expected to Reach USD 3049.97 Million | Current Trends and Research Devel - PharmiWeb.com